SCHEMBL7487355

SCHEMBL7487355

O=C(O)COc1cccc(CC2CCN(Cc3ccccc3)C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 13/20 0.60
FABP4 P15090 2/20 0.49
PTGER4 P35408 3/20 0.48
PTGER3 P43115 2/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TBXA2R P21731 1/20 0.46
PTGER2 P43116 1/20 0.46
PTGDR Q13258 1/20 0.46
CPT2 P23786 1/20 0.40
CPT1A P50416 1/20 0.40
CPT1B Q92523 1/20 0.40
PPARD Q03181 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546572 0.88 PTGIR (0.52) PTGIRPTGER4PTGER3TBXA2RPTGER2
SCHEMBL7490750 0.88 PTGIR (0.59) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL7490972 0.87 PTGIR (0.49) PTGIRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8546568 0.87 PTGIR (0.51) PTGIRPTGER4PTGER3TBXA2RPTGER2
SCHEMBL6611962 0.82 PTGIR (0.86) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL7483613 0.82 PTGIR (0.86) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL8065468 0.82 PTGIR (0.85) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL8065467 0.82 PTGIR (0.85) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL8075310 0.82 PTGIR (0.85) PTGIRFABP4PTGER4PTGER3KDM4E
SCHEMBL7484675 0.82 PTGIR (0.64) PTGIRFABP4PTGER4PTGER3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed